great
variat
among
member
famili
coronavirida
abil
agglutin
red
blood
ceil
member
bovin
coronaviru
bcv
human
coronaviru
hemagglutin
encephalomyel
viru
hev
quit
potent
hemagglutin
agent
studi
bcv
shown
sprotein
major
hemagglutinin
virus
recogn
acid
receptor
determin
cell
coronavirus
possess
anoth
surfac
glycoprotein
less
effici
hemagglutinin
function
receptordestroy
enzym
releas
acetyl
group
posit
similar
hefprotein
influenza
c
viru
sever
coronavirus
eg
porcin
transmiss
gastroenter
viru
tgev
felin
infecti
periton
viru
fipv
avian
infecti
bronchiti
viru
ibv
lack
receptordestroy
enzym
abil
agglutin
red
blood
cell
poor
receptor
determin
recogn
group
virus
previous
identifi
ibv
report
acquir
hemagglutin
activ
treatment
bacteri
phosphoplipas
c
howev
effect
observ
crude
enzym
prepar
use
therefor
induct
hemagglutin
activ
ibv
may
due
contamin
enzym
rather
phospholipas
c
unabl
unmask
hemagglutin
activ
ibv
treatment
viru
reprint
request
address
commerci
avail
phospholipas
c
analyz
whether
neuraminidas
effect
respect
shown
tabl
untreat
viru
unabl
agglutin
chicken
erythrocyt
high
hemagglutin
titer
obtain
treatment
virion
neuraminidas
vibrio
cholera
effect
observ
incub
purifi
hn
protein
newcastl
diseas
viru
also
neuraminidas
activ
enzym
preferenti
cleav
sialic
acid
linkag
galactos
rather
ineffici
releas
sialic
acid
linkag
lo
result
indic
remov
sialic
acid
viral
surfac
requir
ibv
agglutin
red
blood
cell
reason
possibl
explan
inhibitori
effect
surfacebound
sialic
acid
ibv
might
inhibitori
sugar
similar
ident
cellular
receptor
determin
recogn
viru
case
receptor
determin
virion
surfac
would
compet
receptor
determin
cell
surfac
receptorbind
site
viru
consequ
effici
bind
erythrocyt
would
reduc
explain
lack
hemagglutin
activ
model
impli
ibv
use
sialic
acid
receptor
determin
attach
cell
test
possibl
erythrocyt
treat
neuraminidas
analyz
agglutin
neuraminidasetr
ibv
shown
tabl
follow
attach
sialic
acid
surfac
erythrocyt
linkag
ceil
agglutin
ndv
ibv
tabl
former
viru
known
recogn
sialic
acid
receptor
determin
attach
cell
result
indic
ibv
requir
agglutin
erythrocyt
ndv
virus
report
far
use
sialit
acid
attach
cell
found
way
keep
viral
surfac
free
receptor
determin
tabl
order
protect
cell
lysl
deterg
present
sialyltransferas
prepar
fix
erythrocyt
use
experi
glutaraldehyd
min
reovirus
polyomaviru
encephalomyocard
viru
nonenvelop
virus
without
glycoconjug
contain
sialic
acid
envelop
virus
contain
glycoprotein
glycolipid
howev
virus
possess
receptordestroy
enzym
respons
lack
sialic
acid
surfac
neuraminidas
case
influenza
b
virus
paramyxovirus
acetylesteras
case
influenza
c
viru
sever
coronavirus
ibv
first
envelop
viru
report
recogn
sialic
acid
lack
receptordestroy
enzym
sever
way
explain
mask
effect
sialic
acid
hemagglutin
activ
ibv
inhibitori
sialic
acid
virion
might
interact
viral
bind
protein
anoth
viru
particl
result
format
viru
aggreg
ii
sialic
acid
viral
attach
protein
may
part
virion
eg
interact
neighbor
sprotein
iii
sialic
acid
molecul
may
part
cellular
compon
bound
virion
act
inhibitor
viral
hemagglutin
activ
first
possibl
exclud
indic
electron
microscop
analysi
gradient
centrifug
coronavirus
without
receptordestroy
enzym
greater
tendenc
form
aggreg
coronavirus
receptordestroy
enzym
also
unabl
detect
differ
respect
untreat
neuraminidasetr
ibv
shown
futur
work
show
whether
inhibit
due
interact
viral
compon
viru
particl
due
interact
viral
bind
protein
cellular
compon
contain
sialic
acid
find
rais
question
import
viral
bind
activ
mask
receptor
determin
present
virion
surfac
lack
hemagglutin
activ
impli
ibv
unabl
attach
receptor
erythrocyt
condit
agglutin
cell
viru
ie
bridg
mani
erythrocyt
stringent
attach
singl
virion
surfac
singl
cell
thu
despit
lack
hemagglutin
activ
untreat
ibv
might
abl
use
sialic
acidbind
activ
attach
cell
initi
infect
altern
sialic
acidbind
activ
may
mediat
primari
attach
facilit
interact
second
type
receptor
might
necessari
closer
contact
viru
cell
andor
fusion
viral
cellular
membran
latter
possibl
especi
intrigu
combin
two
receptorrecognit
strategi
report
mhvbcv
serogroup
coronavirus
case
bcv
sialic
acid
shown
function
receptor
determin
initi
infect
strain
mhv
murin
member
carcinoembryon
antigen
famili
glycoprotein
identifi
receptor
note
sialic
acid
bind
activ
ibv
analyz
far
erythrocyt
futur
work
cultur
cell
necessari
determin
whether
sialic
acid
involv
initi
infect
studi
perform
transmiss
gastroenter
viru
tgev
anoth
coronaviru
lack
receptordestroy
enzym
like
ibv
tgev
poor
hemagglutinin
preliminari
experi
expect
virus
agglutin
characterist
howev
tgev
grow
readili
cell
cultur
ibv
therefor
suitabl
analyz
role
sialic
acid
viru
infect
famili
corona
e
compris
member
receptordestroy
enzym
eg
bcv
hev
member
lack
enzym
eg
ibv
tgev
fipv
former
group
virus
known
util
sialic
acid
present
surfac
erythrocyt
agglutin
cell
result
obtain
ibv
demonstr
coronaviru
lack
receptordestroy
enzym
also
recogn
sialic
acid
though
differ
subtyp
versu
uniqu
situat
virus
famili
recogn
common
sugar
receptor
determin
attach
cell
member
famili
contain
receptordestroy
enzym
thu
either
coronavirus
acquir
correspond
gene
other
lost
evolut
specul
coronavirus
bcv
acquir
esteras
gene
nonhomolog
recombin
ancestr
coronaviru
influenza
c
viru
certainli
famili
coronavirida
promis
model
evolutionari
studi
acquisit
loss
receptordestroy
enzym
virus
technic
assist
birgit
dbll
phil
davi
grate
acknowledg
work
support
deutsch
forschungsgemeinschaft
fond
der
chemischen
industri
